OTHER GROUP COMPANIES
market

Unichem Laboratories receives USFDA approval for Bystolic? (nebivolol) Tablets

Unichem Laboratories receives USFDA approval for Bystolic? (nebivolol) Tablets

March 16, 2022 10:09 IST | capital market
Unichem Laboratories has received ANDA approval for its Nebivolol Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Bystolic? (nebivolol) Tablets 2.5 mg, 5 mg, 10 mg, and 20 mg, of Allergan Sales, LLC.

Nebivolol Tablets are indicated for the treatment of hypertension. The product will be commercialized from Unichems Ghaziabad Plant.

Powered by Capital Market - Live News

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000

FEATURED ARTICLE

BLOGS

Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity